Ca signaling cross-talk from SR to mitochondria in heart muscle
Ca 信号从 SR 到心肌线粒体的串扰
基本信息
- 批准号:10265413
- 负责人:
- 金额:$ 64.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAffectArchitectureArrhythmiaCardiacCardiac MyocytesCardiovascular DiseasesCationsCellsComplementary DNACouplingCrystallizationCultured CellsDefectDiseaseElectron MicroscopyEndoplasmic ReticulumEpithelial CellsFunctional disorderGenesGeneticHealthHeartHeart DiseasesHeart HypertrophyHeart failureHomeostasisHumanHuman GenomeHypertensionIon ChannelIonsIsoproterenolKnock-outLinkMediatingMembraneMitochondriaMovementMusMuscle CellsMutagenesisMutationMyocardial dysfunctionMyocardiumNamesNeonatalOperative Surgical ProceduresOsteogenesis ImperfectaPathologicPathologyPatientsPeptidesPermeabilityPhasePhysiologicalPhysiologyProtein IsoformsProteinsRNA InterferenceRegulationResearchRoleRyR2Ryanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumSignal TransductionSkeletal MuscleSmooth MuscleStressStructureSystemTailTestingTissuesToxic effectTransgenic Organismsairway epitheliumbiological adaptation to stresscardiogenesiscell typeconstrictioncoronary fibrosisdesignexperimental studyheart functionin vivomRNA Differential Displaysmitochondrial dysfunctionmouse genomemutantnovelpupreceptorreconstitutionrespiratorysynthetic peptide
项目摘要
Project Summary
Mitochondria and sarcoplasmic reticulum (SR) form close interfaces in cardiomyocytes where the
propagation of Ca signals from SR to mitochondria contributes to heart function under physiologic and
pathologic conditions. TRIC is a novel class of trimeric intracellular cation channels located at the SR
or endoplasmic reticulum (ER) of multiple cell types, which function as counter-ion channels that allow
flow of K ions into the SR/ER during the acute phase of Ca release. Genetic ablations or mutations of
TRIC channels are associated with hypertension, heart disease, respiratory defects and brittle bone
disease. The recent crystal structure of TRIC proteins confirms the homotrimeric architecture of a
cation channel. Within the human and mouse genomes, there are two TRIC isoforms, TRIC-A and
TRIC-B, that display differential functions in regulation of Ca signaling in excitable and non-excitable
cells. While our past research efforts primarily focused on understanding the physiological function for
TRIC-A in skeletal and smooth muscle and to a lesser extent the role of TRIC-B in epithelial cells, the
role of TRIC in cardiac physiology and disease remains largely unexplored. Here we present evidence
that TRIC-A, in addition to modulation of the SR permeability to K ions, functions as an integral
component of the physiological control mechanism of Ca signaling in cardiac muscle. We found that the
carboxyl-tail domain of TRIC-A interacts with the RyR2 channel to directly modulate Ca release from the
SR. The TRIC-A-/- mice develop arrhythmia, severe cardiac hypertrophy and fibrosis following
isoproterenol treatment or transverse aortic constriction (TAC) surgery. Isolated TRIC-A-/-
cardiomtocytes display mitochondria dysfunction that likely reflects SR Ca overload-induced
mitochondria toxicity under stress conditions. As uncontrolled Ca release has been implicated in
mitochondrial dysfunction in cardiac pathology, we hypothesize that “TRIC interaction with RyR2
modulates SR Ca release and crosstalk with mitochondria. Absence of TRIC leads to Ca overload
inside SR and causes stress-induced Ca toxicity to mitochondria. The dysregulated SR-mitochondria
crosstalk contributes to the development of heart failure”. We further propose that targeting TRIC-
mediated SR-mitochondria crosstalk represents a novel means for treatment of cardiovascular
diseases. Our experiments designed in this project contain two specific aims: Aim 1 - to define the
functional interaction between TRIC-A/B and RyR2 in regulating the cross-talk of Ca signaling from SR
to mitochondria in cardiomyocytes under physiologic and pathologic conditions; and Aim 2 - to elucidate
the in vivo role of TRIC-A in mediating stress-induced changes in heart function.
项目摘要
线粒体和肌浆网(SR)在心肌细胞中形成紧密的界面,其中
钙信号从SR到线粒体的传播有助于生理和心理状态下的心脏功能
病理情况。TRIC是一类新的位于SR的三聚体细胞内阳离子通道
或多种细胞类型的内质网(ER),它们的功能是反离子通道,允许
钙释放急性期K离子流入SR/ER。基因消融或突变
经络与高血压、心脏病、呼吸缺陷和脆性骨骼有关
疾病。最近蛋白质的晶体结构证实了一个同源三聚体的构型
阳离子通道。在人类和小鼠的基因组中,有两种tre异构体,trc-A和trc-A。
在兴奋性和非兴奋性钙信号调节中显示不同功能的trc-B
细胞。虽然我们过去的研究工作主要集中在了解大脑的生理功能
Tre-A在骨骼肌和平滑肌中的作用,以及在较小程度上在上皮细胞中的作用,
TIC在心脏生理学和疾病中的作用在很大程度上尚不清楚。在这里,我们展示了证据
除了调节SR对K离子的渗透性外,TIC-A还起着积分的作用
心肌钙信号生理调控机制的组成部分。我们发现,
TRIC-A的羧基-尾部结构域与RyR2通道相互作用,直接调节细胞内钙释放。
高级小鼠出现心律失常、严重的心肌肥大和纤维化。
异丙肾上腺素治疗或横断主动脉缩窄(TAC)手术。隔离TIC-A-/-
心肌细胞显示线粒体功能障碍,这可能反映了肌浆网钙超载引起的
应激条件下线粒体的毒性。由于不受控制的钙释放被认为与
在心脏病理中,线粒体功能障碍,我们假设与RyR2相互作用
调节肌浆网钙的释放和与线粒体的串扰。缺铁性钙导致钙超载
内质网,并对线粒体造成应激诱导的钙毒性。调节失调的SR-线粒体
相声有助于心力衰竭的发展。我们进一步建议将目标对准TICRIC-
介导的SR-线粒体串扰是治疗心血管疾病的新手段
疾病。我们在这个项目中设计的实验包含两个特定的目标:目标1-定义
Trc-A/B和RyR2在调节SR钙信号串扰中的功能相互作用
在生理和病理条件下对心肌细胞线粒体的影响;和目的2-阐明
TRIC-A在体内调节应激诱导的心功能改变中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pei-Hui Lin其他文献
Pei-Hui Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pei-Hui Lin', 18)}}的其他基金
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure
针对细胞因子/趋化因子的异常表达来治疗炎症性肾炎
- 批准号:
10525534 - 财政年份:2022
- 资助金额:
$ 64.75万 - 项目类别:
Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis Cure
针对细胞因子/趋化因子的异常表达来治疗炎症性肾炎
- 批准号:
10651843 - 财政年份:2022
- 资助金额:
$ 64.75万 - 项目类别:
Muscle-Kidney Crosstalk in Age-related Kidney Disease
年龄相关性肾脏疾病中的肌肉-肾脏串扰
- 批准号:
10244886 - 财政年份:2020
- 资助金额:
$ 64.75万 - 项目类别:
Muscle-Kidney Crosstalk in Age-related Kidney Disease
年龄相关性肾脏疾病中的肌肉-肾脏串扰
- 批准号:
10399649 - 财政年份:2020
- 资助金额:
$ 64.75万 - 项目类别:
Muscle-Kidney Crosstalk in Age-related Kidney Disease
年龄相关性肾脏疾病中的肌肉-肾脏串扰
- 批准号:
9887283 - 财政年份:2020
- 资助金额:
$ 64.75万 - 项目类别:
Ca signaling cross-talk from SR to mitochondria in heart muscle
Ca 信号从 SR 到心肌线粒体的串扰
- 批准号:
9908165 - 财政年份:2018
- 资助金额:
$ 64.75万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 64.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 64.75万 - 项目类别:
Standard Grant